The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors
Abstract
Benign peripheral nerve sheath tumors (PNSTs) are a characteristic feature of neurofibromatosis type I (NF1) patients. NF1 individuals have an 8–13% lifetime risk of developing a malignant PNST (MPNST). Atypical neurofibromas are symptomatic, hypercellular PNSTs, composed of cells with hyperchromatic nuclei in the absence of mitoses. Little is known about the origin and nature of atypical neurofibromas in NF1 patients. In this study, we classified the atypical neurofibromas in the spectrum of NF1‐associated PNSTs by analyzing 65 tumor samples from 48 NF1 patients. We compared tumor‐specific chromosomal copy number alterations between benign neurofibromas, atypical neurofibromas, and MPNSTs (low‐, intermediate‐, and high‐grade) by karyotyping and microarray‐based comparative genome hybridization (aCGH). In 15 benign neurofibromas (4 subcutaneous and 11 plexiform), no copy number alterations were found, except a single event in a plexiform neurofibroma. One highly significant recurrent aberration (15/16) was identified in the atypical neurofibromas, namely a deletion with a minimal overlapping region (MOR) in chromosome band 9p21.3, including CDKN2A and CDKN2B. Copy number loss of the CDKN2A/B gene locus was one of the most common events in the group of MPNSTs, with deletions in low‐, intermediate‐, and high‐grade MPNSTs. In one tumor, we observed a clear transition from a benign‐atypical neurofibroma toward an intermediate‐grade MPNST, confirmed by both histopathology and aCGH analysis. These data support the hypothesis that atypical neurofibromas are premalignant tumors, with the CDKN2A/B deletion as the first step in the progression toward MPNST. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Cawthon, R. M., Weiss, R., Xu, G., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90253-b · Cited by 1,094
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
Martin, G. A., Viskoohil, D., Bollag, G., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R. M., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90150-d · Cited by 982
Guillou, L., Coindre, J. M., Bonichon, F., Nguyen, B. B., Terrier, P., Collin, F., Vilain, M. O., Mandard, A. M., Le Doussal, V, Leroux, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.350 · Cited by 864
Menon, A. G., Anderson, K. M., Riccardi, V. M., Chung, R. Y., Whaley, J. M., Yandell, D. W., Farmer, G. E., Freiman, R. N., Lee, J. K., & Li, F. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5435 · Cited by 395
Legius, E., Marchuk, D. A., Collins, F. S., & Glover, T. W. (1993) · Nature Genetics · doi:10.1038/ng0293-122 · Cited by 391
Self-citationMechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
Brems, H., Beert, E., de Ravel, T., & Legius, E. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70033-6 · Cited by 349
Self-citationElevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
Self-citationVeeriah, S., Brennan, C., Meng, S., Singh, B., Fagin, J. A., Solit, D. B., Paty, P. B., Rohle, D., Vivanco, I., Chmielecki, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900571106 · Cited by 299
RB and hbrm cooperate to repress the activation functions of E2F1
Trouche, D., Le Chalony, C., Muchardt, C., Yaniv, M., & Kouzarides, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11268 · Cited by 294
Ferner, R. E., Golding, J. F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V., & O’Doherty, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm450 · Cited by 286
Nielsen, G. P., Stemmer-Rachamimov, A. O., Ino, Y., Møller, M. B., Rosenberg, A. E., & Louis, D. N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65507-1 · Cited by 266
Serra, E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3055 · Cited by 254
TP53 mutations are frequent in malignant NFI tumors
Legius, E., Dierick, H., Wu, R., Hall, B. K., Marynen, P., Cassiman, J., & Glover, T. W. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870100405 · Cited by 195
Self-citationKourea, H. P., Orlow, I., Scheithauer, B. W., Cordon-Cardo, C., & Woodruff, J. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65504-6 · Cited by 170
Tumors of the Peripheral Nervous System
Antonescu, C. R., Scheithauer, B. W., & Woodruff, J. M. (2013) · doi:10.55418/9781933477305 · Cited by 157
Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group
Mertens, F., Cin, P. D., Wever, I. D., Fletcher, C. D. �., Mandahl, N., Mitelman, F., Rosaí, J., Rydholm, A., Sciot, R., Tallini, G., et al. (2000) · The Journal of Pathology · Cited by 148
Self-citationKehrer‐Sawatzki, H., Kluwe, L., Sandig, C., Kohn, M., Wimmer, K., Krammer, U., Peyrl, A., Jenne, D. E., Hansmann, I., & Mautner, V. (2004) · The American Journal of Human Genetics · doi:10.1086/423624 · Cited by 147
Self-citationMolecular and cytogenetic analysis of tumors in von recklinghausen neurofibromatosis
Glover, T. W., Stein, C. K., Legius, E., Andersen, L. B., Brereton, A., & Johnson, S. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030111 · Cited by 145
Self-citationMantripragada, K. K., Spurlock, G., Kluwe, L., Chuzhanova, N. A., Ferner, R. E., Frayling, I. M., Dumanski, J. P., Guha, A., Mautner, V., & Upadhyaya, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1305 · Cited by 129
Self-citationRb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath Tumors
Birindelli, S., Perrone, F., Oggionni, M., Lavarino, C. E., Pasini, B., Vergani, B., Ranzani, G. N., Pierotti, M. A., & Pilotti, S. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780293 · Cited by 121
Holtkamp, N., Okuducu, A. F., Mucha, J., Afanasieva, A., Hartmann, C. J., Atallah, I., Estévéz‐Schwarz, L., Mawrin, C., Friedrich, R. E., Mautner, V., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi273 · Cited by 93
Self-citationPerrone, F., Tabano, S. M., Colombo, F., Dagrada, G. P., Birindelli, S., Gronchi, A., Colecchia, M., Pierotti, M. A., & Pilotti, S. (2003) · PubMed · Cited by 81
Lothe, R. A., Karhu, R., Mandahl, N., Mertens, F., Sæter, G. E., Heim, S., Børresen‐Dale, A., & Kallioniemi, O. (1996) · PubMed · Cited by 77
Klijn, C. N., Holstege, H. H., de Ridder, J., Liu, X., Reinders, M. J. T., Jonkers, J., & Wessels, L. F. A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1143 · Cited by 70
Schmidt, H., Taubert, H. W., Meye, A., Würl, P., Bache, M., Bartel, F., Holzhausen, H.-J., & Hinze, R. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00426-2 · Cited by 69
TP53 Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors
Verdijk, R. M., den Bakker, M. A., Dubbink, H. J., Hop, W. C. J., Dinjens, W. N. M., & Kros, J. M. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c55d55 · Cited by 68
Spurlock, G., Knight, S. J. L., Thomas, N. S. T., Kiehl, T., Guha, A., & Upadhyaya, M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0846-3 · Cited by 61
Storlazzi, C. T., Brekke, H. R., Mandahl, N., Brosjö, O., Smeland, S., Lothe, R. A., & Mertens, F. (2006) · The Journal of Pathology · doi:10.1002/path.1998 · Cited by 55
Mantripragada, K. K., de Ståhl, T. D., Patridge, C., Menzel, U., Andersson, R., Chuzhanova, N. A., Kluwe, L., Guha, A., Mautner, V., Dumanski, J. P., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20695 · Cited by 55
Self-citation
Cited by
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Dombi, E., Baldwin, A., Marcus, L. J., Fisher, M. J., Weiss, B., Kim, A., Whitcomb, P., Martin, S., Aschbacher-Smith, L. E., Rizvi, T. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605943 · Cited by 682
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Ratner, N., & Miller, S. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3911 · Cited by 493
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
De Raedt, T., Beert, E., Pasmant, E., Luscan, A., Brems, H., Ortonne, N., Helin, K., Hornick, J. L., Mautner, V., Kehrer-Sawatzki, H., et al. (2014) · Nature · doi:10.1038/nature13561 · Cited by 461
Self-citationMiettinen, M. M., Antonescu, C. R., Fletcher, C. D. M., Kim, A., Lazar, A. J., Quezado, M. M., Reilly, K. M., Stemmer-Rachamimov, A., Stewart, D. R., Viskochil, D., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.05.010 · Cited by 439
Metadata
- Authors
- Beert, E., Brems, H., Daniëls, B., De Wever, I., Van Calenbergh, F., Schoenaers, J., Debiec‐Rychter, M., Gevaert, O., De Raedt, T., Van Den Bruel, A., de Ravel, T., Cichowski, K., Kluwe, L., Mautner, V., Sciot, R., & Legius, E.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2011-08-24
- Volume
- 50
- Issue
- 12
- Pages
- 1021-1032
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W1967830748
- Cited by
- 255
- References
- 32
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.